Xinguo Wang , Juan Dong , Hao Sheng, Xingting Ma, Lazati Baheti, Jie Xu
{"title":"Coding RNA expression profile and transcription factor analysis of H.pylori-associated chronic atrophic gastritis","authors":"Xinguo Wang , Juan Dong , Hao Sheng, Xingting Ma, Lazati Baheti, Jie Xu","doi":"10.1016/j.advms.2023.10.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p><span>Atrophic gastritis, one of the processes leading to gastric cancer (GC), is closely related to </span><span><em>Helicobacter pylori</em></span><span><span> (HP) infection. This study aimed to understand how HP causes chronic inflammation that leads to </span>ulcers and stomach problems.</span></p></div><div><h3>Methods</h3><p><span>Twenty-eight CAG patients were included in the study (9 HP-infected and 19 HP-uninfected). Endoscopy, </span>histopathology, and high-throughput mRNA sequencing were performed. Differentially expressed genes (DEGs) were validated via qRT-PCR.</p></div><div><h3>Results</h3><p><span><span><span>Principal component analysis<span><span> (PCA) results showed that more than 88.9 % of the samples were classified into the HP (+) group. A total of 157 DEGs were identified, of which 38 were up-regulated and 119 were down-regulated. The DEGs were mainly enriched in the biological process (BP) terms associated with immune system process, </span>adaptive immune response, G protein-coupled receptor </span></span>signaling pathway<span><span>, as well as point to numerous key pathways, including fat digestion and absorption, retinol metabolism, </span>steroid hormone biosynthesis, </span></span>ascorbate<span> and aldarate metabolism, and chemical carcinogenesis. </span></span><em>APOA1</em>, <span><em>APOA4</em></span>, <span><em>FOXP3</em></span>, <em>NR1H4</em>, <span><em>ABCG5</em></span>, <em>ACTA1</em>, <span><em>CCL19</em></span>, <em>CCR7</em>, <span><em>CYP3A4</em></span>, and <em>PDCD</em><span> had the highest degrees in protein–protein interaction network as the hub genes; they were also included into the transcription factor (TF)-target network except for </span><em>PDCD</em>. <em>APOA1</em> and <em>CYP3A4</em> were extremely significantly up-regulated in HP (+) CAG patients compared with the HP (−) CAG patients, while <em>FOXP3</em>, <em>CCR7</em> and <em>CCL19</em> were significantly down-regulated.</p></div><div><h3>Conclusion</h3><p>The expression of <em>APOA1</em>, <em>CYP3A4</em>, <em>FOXP3</em>, <em>CCR7</em>, and <em>CCL19</em> are the potential indicators for CAG to GC development, being the biomarkers to predict progression of CAG and poor prognosis of GC.</p></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"68 2","pages":"Pages 491-498"},"PeriodicalIF":2.5000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in medical sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1896112623000470","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
Atrophic gastritis, one of the processes leading to gastric cancer (GC), is closely related to Helicobacter pylori (HP) infection. This study aimed to understand how HP causes chronic inflammation that leads to ulcers and stomach problems.
Methods
Twenty-eight CAG patients were included in the study (9 HP-infected and 19 HP-uninfected). Endoscopy, histopathology, and high-throughput mRNA sequencing were performed. Differentially expressed genes (DEGs) were validated via qRT-PCR.
Results
Principal component analysis (PCA) results showed that more than 88.9 % of the samples were classified into the HP (+) group. A total of 157 DEGs were identified, of which 38 were up-regulated and 119 were down-regulated. The DEGs were mainly enriched in the biological process (BP) terms associated with immune system process, adaptive immune response, G protein-coupled receptor signaling pathway, as well as point to numerous key pathways, including fat digestion and absorption, retinol metabolism, steroid hormone biosynthesis, ascorbate and aldarate metabolism, and chemical carcinogenesis. APOA1, APOA4, FOXP3, NR1H4, ABCG5, ACTA1, CCL19, CCR7, CYP3A4, and PDCD had the highest degrees in protein–protein interaction network as the hub genes; they were also included into the transcription factor (TF)-target network except for PDCD. APOA1 and CYP3A4 were extremely significantly up-regulated in HP (+) CAG patients compared with the HP (−) CAG patients, while FOXP3, CCR7 and CCL19 were significantly down-regulated.
Conclusion
The expression of APOA1, CYP3A4, FOXP3, CCR7, and CCL19 are the potential indicators for CAG to GC development, being the biomarkers to predict progression of CAG and poor prognosis of GC.
期刊介绍:
Advances in Medical Sciences is an international, peer-reviewed journal that welcomes original research articles and reviews on current advances in life sciences, preclinical and clinical medicine, and related disciplines.
The Journal’s primary aim is to make every effort to contribute to progress in medical sciences. The strive is to bridge laboratory and clinical settings with cutting edge research findings and new developments.
Advances in Medical Sciences publishes articles which bring novel insights into diagnostic and molecular imaging, offering essential prior knowledge for diagnosis and treatment indispensable in all areas of medical sciences. It also publishes articles on pathological sciences giving foundation knowledge on the overall study of human diseases. Through its publications Advances in Medical Sciences also stresses the importance of pharmaceutical sciences as a rapidly and ever expanding area of research on drug design, development, action and evaluation contributing significantly to a variety of scientific disciplines.
The journal welcomes submissions from the following disciplines:
General and internal medicine,
Cancer research,
Genetics,
Endocrinology,
Gastroenterology,
Cardiology and Cardiovascular Medicine,
Immunology and Allergy,
Pathology and Forensic Medicine,
Cell and molecular Biology,
Haematology,
Biochemistry,
Clinical and Experimental Pathology.